SEC Filing Summary: Charles River Laboratories International, Inc.
Business Context and Reporting Period
This Form 8-K, dated August 5, 2026, reports the issuance of a press release containing financial results for the second quarter ended June 27, 2026. The filing serves as a notification of these results and includes forward-looking statements protected under the Private Securities Litigation Reform Act of 1995.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the provided text.
Material Changes
The filing text does not provide data to compare current period performance against prior comparable periods. Specific details regarding material changes are located in the referenced press release.
Guidance, Outlook, and Risks
Management commentary and forward-looking statements regarding guidance and outlook are included in the attached press release. The filing explicitly notes that risks relating to the company are set forth in other documents filed with the Securities and Exchange Commission. No specific risks or contingencies are detailed in the body of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 5, 2026) for specific Q2 2026 financial figures.
- Verify forward-looking statements and associated risk factors in the press release and recent 10-K/10-Q filings.
- Confirm the exact quarter end date of June 27, 2026, for accurate period comparison.
- Check for any unusual items or non-GAAP adjustments detailed in the attached press release.